Mizuho Upgrades LifeMD Inc (LFMD) to Outperform

March 16, 2026 4:15 AM

Mizuho analyst Steven Valiquette upgraded LifeMD Inc (NASDAQ: LFMD) from Neutral to Outperform with a price target of $8.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found